Tanya Labonne

Details

Role Laboratory Manager / Research Assistant

Research area Stem Cell Medicine

Group Immune Development

Stolper, J, Voges, HK, See, M, Mehdiabadi, NR, Chahal, G, Drvodelic, M, Eichenlaub, M, Labonne, T, Schultz, BG, Hidalgo, A, et al. The human FLT1 regulatory element directs vascular expression and modulates angiogenesis pathways in vitro and in vivo. 2024
view publication
Saxena, R, Elefanty, A, Labonne, T, Ng, E, Stanley, E. 3170 – TRACKING DEVELOPMENT OF RUNX1+ HEMOGENIC ENDOTHELIUM IN VITRO. Experimental Hematology 124: s134 2023
view publication
Ng, E, Li, J, Saxena, R, Edirisinghe, H, Sarila, G, Bruveris, F, Sun, S, Labonne, T, Calvanese, V, Capellera-Garcia, S, et al. 2014 – MULTI-LINEAGE ENGRAFTMENT OF INDUCED HEMATOPOIETIC STEM CELLS (IHSCS) DIFFERENTIATED FROM HUMAN PLURIPOTENT STEM CELLS. Experimental Hematology 111: s38 2022
view publication
Saxena, R, Ng, E, Elefanty, A, Stanley, E, Labonne, T. 3180 – RECAPITULATING INTRA-EMBRYONIC HAEMATOPOIESIS IN VITRO USING PLURIPOTENT STEM CELLS. Experimental Hematology 111: s134 -s135 2022
view publication
Labonne, T, Elefanty, AG, Stanley, EG, Schiesser, JV. An INSULIN-GFP/GLUCAGON-mCherry reporter line for the study of human pancreatic endocrine cell development.. Stem Cell Res 56: 102547 2021
view publication